BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$54.89 USD
+0.16 (0.29%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $54.90 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
For Bio-Techne Corp, the company has a dividend yield of 0.58% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TECH 54.89 +0.16(0.29%)
Will TECH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TECH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TECH
INCY or TECH: Which Is the Better Value Stock Right Now?
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock
TECH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Techne (TECH) Down 3% Since Last Earnings Report?
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
Bio-Techne Q3 Earnings & Revenues Top Estimates, Stock Up in Premarket
Other News for TECH
Ford's EV Tease, Tesla's Legal Woes, Boeing's Negligence Lawsuit And More: This Week In Mobility
AI Surprises Bill Gates, Meta And Microsoft Unleash AI Tsunami And More: This Week In AI
Apple's Surprising Quarter, Tariff Concerns, AI Acquisitions And More: This Week In Appleverse
Consumer Tech News (July 28–August 1): Earnings From Apple, Microsoft, and Amazon Offset by Fed Jitters, Tariff Woes
Steve Jobs Once Said Making Something Great Doesn't Require 'More Energy' Or 'More Money,' But Does Require This One Skill In Abundance